Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
German Center for Neurodegenerative Diseases · University of Helsinki · +19 more institutions
Abstract
Another host factor for SARS-CoV-2 Virus-host interactions determine cellular entry and spreading in tissues. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the earlier SARS-CoV use angiotensin-converting enzyme 2 (ACE2) as a receptor; however, their tissue tropism differs, raising the possibility that additional host factors are involved. The spike protein of SARS-CoV-2 contains a cleavage site for the protease furin that is absent from SARS-CoV (see the Perspective by Kielian). Cantuti-Castelvetri et al. now show that neuropilin-1 (NRP1), which is known to bind furin-cleaved substrates, potentiates SARS-CoV-2 infectivity. NRP1 is abundantly expressed in the respiratory and olfactory…
Citation impact
- FWCI
- 196.19
- Percentile
- 100%
- References
- 38
Authors
29- LCLudovico Cantuti‐CastelvetriCorresponding
German Center for Neurodegenerative Diseases
- RORavi OjhaCorresponding
University of Helsinki
- LDLiliana D. PedroCorresponding
German Center for Neurodegenerative Diseases
- MDMinou DjannatianCorresponding
German Center for Neurodegenerative Diseases
- JFJonas FranzCorresponding
Universitätsmedizin Göttingen, Max Planck Institute of Experimental Medicine, University of Göttingen
Topics & keywords
- Furin
- Tropism
- Neuropilin 1
- Viral entry
- Biology
- Virology
- Coronavirus
- Infectivity
- Good health and well-being
Funding
- DMDr. Miriam and Sheldon G. Adelson Medical Research Foundation
- HYHelsingin Yliopisto
- WTWellcome TrustAward: WT095077MA
- DFDeutsche ForschungsgemeinschaftAwards: EXC 2067/1-390729940, EXC 2067, TRR274, TRR274-1, TRR128, EXC2145, SPP2191, TRR128-2, STA 1389/5-1, 390729940, 2067/1-390729940, Projekt ID390857198, ID390857198, EXC 2067/1
- ETEesti TeadusagentuurAwards: PRG230, 2014-2020, 2014-2020.4.01.15-0012, EAG79
- JJJane ja Aatos Erkon SäätiöAward: 874735
- MRMedical Research CouncilAwards: MR/R020566/1, MR/P018807/1, MR/T028769/1
- ARAustralian Research CouncilAwards: DE190100565, GNT1155794
- NHNational Health and Medical Research CouncilAward: GNT1155794
- EREuropean Regional Development FundAwards: WT095077MA, 2014-2020.4.01.15-0012, 2014-2020, CC BY 4.0
- HEHORIZON EUROPE Marie Sklodowska-Curie Actions